Free Trial

Avalo Therapeutics (AVTX) Competitors

Avalo Therapeutics logo
$4.85 +0.10 (+2.11%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$4.84 -0.01 (-0.31%)
As of 07/8/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVTX vs. SOPH, MNPR, SCPH, DSGN, VOR, ACIU, ESPR, PROK, KOD, and SLS

Should you be buying Avalo Therapeutics stock or one of its competitors? The main competitors of Avalo Therapeutics include SOPHiA GENETICS (SOPH), Monopar Therapeutics (MNPR), scPharmaceuticals (SCPH), Design Therapeutics (DSGN), Vor Biopharma (VOR), AC Immune (ACIU), Esperion Therapeutics (ESPR), ProKidney (PROK), Kodiak Sciences (KOD), and SELLAS Life Sciences Group (SLS). These companies are all part of the "pharmaceutical products" industry.

Avalo Therapeutics vs. Its Competitors

SOPHiA GENETICS (NASDAQ:SOPH) and Avalo Therapeutics (NASDAQ:AVTX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

SOPHiA GENETICS currently has a consensus price target of $7.00, indicating a potential upside of 96.63%. Avalo Therapeutics has a consensus price target of $30.00, indicating a potential upside of 518.56%. Given Avalo Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Avalo Therapeutics is more favorable than SOPHiA GENETICS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SOPHiA GENETICS
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Avalo Therapeutics
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

SOPHiA GENETICS has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, Avalo Therapeutics has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.

In the previous week, Avalo Therapeutics had 2 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 3 mentions for Avalo Therapeutics and 1 mentions for SOPHiA GENETICS. Avalo Therapeutics' average media sentiment score of 0.34 beat SOPHiA GENETICS's score of 0.00 indicating that Avalo Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SOPHiA GENETICS
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avalo Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Avalo Therapeutics has a net margin of 0.00% compared to SOPHiA GENETICS's net margin of -98.51%. Avalo Therapeutics' return on equity of 111.00% beat SOPHiA GENETICS's return on equity.

Company Net Margins Return on Equity Return on Assets
SOPHiA GENETICS-98.51% -63.47% -40.06%
Avalo Therapeutics N/A 111.00%58.88%

31.6% of SOPHiA GENETICS shares are held by institutional investors. Comparatively, 87.1% of Avalo Therapeutics shares are held by institutional investors. 4.9% of SOPHiA GENETICS shares are held by insiders. Comparatively, 0.3% of Avalo Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Avalo Therapeutics has lower revenue, but higher earnings than SOPHiA GENETICS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SOPHiA GENETICS$65.17M3.64-$62.49M-$1.00-3.56
Avalo Therapeutics$440K119.38-$35.13MN/AN/A

Summary

Avalo Therapeutics beats SOPHiA GENETICS on 11 of the 14 factors compared between the two stocks.

Get Avalo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVTX vs. The Competition

MetricAvalo TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$51.43M$2.39B$5.47B$8.95B
Dividend YieldN/A1.80%5.25%4.04%
P/E RatioN/A8.9826.9620.11
Price / Sales119.38729.50430.20119.79
Price / CashN/A159.8036.8257.86
Price / Book0.384.517.985.56
Net Income-$35.13M$31.26M$3.16B$248.40M
7 Day Performance-1.82%3.57%2.39%4.67%
1 Month Performance6.36%1.28%2.18%6.64%
1 Year Performance-62.29%1.08%33.82%21.31%

Avalo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTX
Avalo Therapeutics
2.9916 of 5 stars
$4.85
+2.1%
$30.00
+518.6%
-63.1%$51.43M$440K0.0040
SOPH
SOPHiA GENETICS
2.3499 of 5 stars
$3.10
+0.3%
$7.00
+125.8%
-21.2%$206.06M$65.17M-3.10520News Coverage
Positive News
MNPR
Monopar Therapeutics
2.8955 of 5 stars
$35.78
+6.5%
$56.50
+57.9%
+940.0%$205.47MN/A-10.2810News Coverage
Analyst Forecast
Gap Up
SCPH
scPharmaceuticals
4.1317 of 5 stars
$3.81
-1.6%
$14.00
+267.5%
-9.4%$204.30M$36.33M-1.9930
DSGN
Design Therapeutics
0.3745 of 5 stars
$3.37
-5.6%
$4.00
+18.7%
+4.0%$202.66MN/A-3.4040Positive News
VOR
Vor Biopharma
3.9433 of 5 stars
$1.62
+52.8%
$5.63
+247.4%
+164.9%$202.44MN/A-0.98140Options Volume
Gap Up
High Trading Volume
ACIU
AC Immune
2.7562 of 5 stars
$2.03
+1.0%
$12.00
+491.1%
-40.5%$201.82M$31.02M-3.50140
ESPR
Esperion Therapeutics
4.2262 of 5 stars
$0.98
-0.9%
$7.00
+611.1%
-51.3%$196.93M$332.31M-1.23200Positive News
PROK
ProKidney
0.7394 of 5 stars
$0.59
-11.5%
$3.50
+491.1%
+68.8%$195.73M$80K-0.993Trending News
Gap Up
High Trading Volume
KOD
Kodiak Sciences
4.1283 of 5 stars
$3.73
+0.8%
$9.00
+141.3%
+58.5%$195.23MN/A-1.0390News Coverage
SLS
SELLAS Life Sciences Group
0.1221 of 5 stars
$2.19
+12.3%
N/A+77.9%$194.57M$1M-5.7610High Trading Volume

Related Companies and Tools


This page (NASDAQ:AVTX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners